Wanbury Ltd's Q3FY25 Quarter Results
- 13 Feb 2025
Result Summary
- Wanbury Ltd reported a 17.5% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a decline of 8.1%.
- Its expenses for the quarter were down by 14.0% QoQ and 2.2% YoY.
- The net profit decreased 84.8% QoQ and decreased 88.1% YoY.
- The earnings per share (EPS) of Wanbury Ltd stood at 0.3 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 134.29 | 162.82 | 146.19 | -17.5% | -8.1% |
Total Expenses | 133.00 | 154.65 | 135.93 | -14.0% | -2.2% |
Profit Before Tax | 1.29 | 8.17 | 10.26 | -84.2% | -87.4% |
Tax | 0.07 | 0.15 | -0.02 | -53.3% | -450.0% |
Profit After Tax | 1.22 | 8.02 | 10.27 | -84.8% | -88.1% |
Earnings Per Share | 0.30 | 2.30 | 3.10 | -87.0% | -90.3% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Wanbury Ltd is a company primarily engaged in the pharmaceutical industry. It is known for manufacturing and marketing a wide range of pharmaceutical products, including active pharmaceutical ingredients (APIs) and formulations. The company plays an important role in delivering healthcare solutions across various therapeutic segments. As of the latest updates, Wanbury Ltd has been focusing on expanding its product portfolio and strengthening its market presence both domestically and internationally. However, specific recent major developments for Wanbury Ltd are not available in the provided data.
Revenue
In the third quarter of the financial year 2025 (Q3FY25), Wanbury Ltd reported a total income of ₹134.29 crores. This represents a decrease of 17.5% compared to the previous quarter (Q2FY25), where the total income was ₹162.82 crores. Additionally, there was a year-over-year decrease of 8.1% when compared to Q3FY24, where the total income was ₹146.19 crores. This decline in revenue over both the quarter-over-quarter (QoQ) and year-over-year (YoY) periods is a notable aspect of the company's financial performance for this quarter.
Profitability
The profitability metrics for Wanbury Ltd in Q3FY25 indicate a significant reduction. The company reported a profit before tax of ₹1.29 crores, marking an 84.2% decrease from the previous quarter (Q2FY25) and an 87.4% decrease from the same quarter in the previous year (Q3FY24). The tax expense for Q3FY25 was ₹0.07 crores, which decreased by 53.3% from Q2FY25, but significantly increased from a negative tax (tax benefit) of ₹0.02 crores in Q3FY24. Consequently, the profit after tax for Q3FY25 was ₹1.22 crores, showing an 84.8% decrease QoQ and an 88.1% decrease YoY. These figures reflect substantial reductions in profitability for Wanbury Ltd during this period.
Operating Metrics
Wanbury Ltd's operating metrics for Q3FY25 present a challenging picture. Total expenses for the quarter were ₹133.00 crores, decreasing by 14.0% from ₹154.65 crores in Q2FY25 and by 2.2% from ₹135.93 crores in Q3FY24. Despite the reduction in expenses, the significant decrease in total income impacted the company's profitability. The earnings per share (EPS) for Q3FY25 stood at ₹0.30, reflecting an 87.0% decline QoQ and a 90.3% decline YoY from ₹2.30 in Q2FY25 and ₹3.10 in Q3FY24, respectively. This substantial decrease in EPS highlights the impact of reduced profitability on shareholder returns during the quarter. However, specific calculations for key financial ratios such as P/E ratio, debt-to-equity ratio, or current ratio are not possible with the provided data.
